A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254

NCT03575962 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: GSK3640254 bis-hydrochloride salt capsule
DRUG: GSK3640254 Mesylate Salt Capsule

Sponsor

ViiV Healthcare